临床试验成像的全球市场(2023年~2033年)
市场调查报告书
商品编码
1266906

临床试验成像的全球市场(2023年~2033年)

Clinical Trial Imaging Market Report 2023-2033

出版日期: | 出版商: Visiongain Reports Ltd. | 英文 272 Pages | 商品交期: 最快1-2个工作天内

价格

全球临床试验成像的市场规模,至2033年预计以7.5%的年复合成长率成长。对精确和个性化治疗的需求增加,促进临床试验数增加,市场成长。

本报告提供全球临床试验成像市场的相关调查,市场概要,市场分析,企业简介等全面性资讯。

目录

第1章 报告概要

第2章 摘要整理

第3章 市场概要

  • 主要调查结果
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 市场机会
  • COVID-19影响分析
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 竞争企业间的敌对关係
    • 替代品的威胁
    • 新加入业者的威胁
  • PEST分析

第4章 临床试验成像市场分析:软体、各服务

  • 主要调查结果
  • 软体、服务市场区隔:市场魅力指数
  • 临床试验成像市场规模的估计与预测:各软体、服务
  • 服务
  • 软体

第5章 临床试验成像市场分析:各种模式

  • 主要调查结果
  • 模式市场区隔:市场魅力指数
  • 临床试验成像市场规模的估计与预测:各种模式
  • 电脑断层摄影
  • 磁振造影
  • 超音波
  • 正子放出断层摄影
  • X光
  • 心臟超音波检验

第6章 临床试验成像市场分析:各治疗领域

  • 主要调查结果
  • 治疗领域市场区隔:市场魅力指数
  • 临床试验成像市场规模的估计与预测:各治疗领域
  • 肿瘤
  • 感染疾病
  • 神经
  • CVS
  • 内分泌
  • 免疫疾病

第7章 临床试验成像市场分析:各终端用户

  • 主要调查结果
  • 终端用户市场区隔:市场魅力指数
  • 临床试验成像市场规模的估计与预测:各终端用户
  • 製药企业
  • 生物科技企业
  • 医疗设备厂商
  • 受託研究机构
  • 学术、研究机关及政府研究机关

第8章 临床试验成像市场分析:各地区

  • 主要调查结果
  • 地区的市场规模的估计与预测

第9章 北美的临床试验成像市场分析

第10章 欧洲的临床试验成像市场分析

第11章 亚太地区的临床试验成像市场分析

第12章 南美的临床试验成像市场分析

第13章 中东、非洲的临床试验成像市场分析

第14章 企业简介

  • 竞争情形(2022年)
  • 策略的展望
  • ICON plc
  • BioTelemetry, a Philips Company
  • Clario
  • Navitas Life Sciences
  • Resonance Health Ltd
  • Parexel International Corporation
  • Medrio, Inc.
  • Signant Health
  • Perspectum
  • Medical Metrics, Inc.
  • Calyx
  • Radiant Sage LLC
  • Medpace
  • IXICO plc

第15章 结论与建议

  • 结束
  • 对市场相关人员的推荐事项
Product Code: PHA1247

The global Clinical Trial Imaging market is projected to grow at a CAGR of 7.5% by 2033.

“The Clinical Trial Imaging Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors such as Increasing Demand for More Precise and Personalized Treatments and Growing Number of Clinical Trials Are Driving the Market Growth

Clinical trial imaging has the potential to personalize treatments by detecting patients who have specific genetic or disease subtype characteristics that would benefit from a specific drug or treatment. By doing so, the effectiveness of treatments can be enhanced and the possibility of harmful side effects can be reduced. With the increasing demand for novel and enhanced drugs and therapies, the number of clinical trials being conducted worldwide is on the rise. Clinical trial imaging plays a crucial role in these trials by allowing researchers to visualize and quantify the impact of experimental drugs and therapies on the body. Advanced medical imaging techniques like MRI, CT scans, and PET scans offer intricate images of organs, tissues, and cells, enabling identification and monitoring of disease progression, as well as evaluation of the safety and effectiveness of new treatments.

Shortage of Skilled Professional

A major limitation for the clinical trial imaging market is the scarcity of proficient experts. The proficient execution of clinical trial imaging demands skilled professionals such as radiologists, imaging technicians, and data analysts who are trained in the handling of medical imaging technology and possess expertise in data analysis and interpretation. Unfortunately, there is a lack of skilled professionals in the medical imaging field, making it difficult for companies to recruit and retain them. This shortage is more noticeable in emerging markets and specialized areas of imaging, such as nuclear medicine and molecular imaging.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the clinical trial imaging market evolving?
  • What is driving and restraining the clinical trial imaging market?
  • How will each clinical trial imaging submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each clinical trial imaging submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading clinical trial imaging markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2020 and 2033? What are the implications of clinical trial imaging projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial imaging market?
  • Where is the clinical trial imaging market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial imaging market today, and over the next 10 years:

  • Our 272-page report provides 115 tables and 162 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial imaging market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial imaging prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Software and Services

  • Software
  • Services

Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-ray
  • Echocardiography

Therapeutic Area

  • Oncology
  • Infectious Diseases
  • Neurology
  • CVS
  • Endocrinology
  • Immunological Disorder

End-users

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturer
  • Contract Research Organisations
  • Academic and Government Research Institutes

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Russia
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC Countries
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Imaging Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • BioTelemetry, a Philips Company
  • Calyx
  • Clario
  • eClinical Solutions LLC
  • ICON plc
  • IXICO plc
  • Medical Metrics, Inc
  • Medpace
  • Medrio, Inc
  • Novitas Life Sciences
  • Parexel International Corporation
  • Perspectum
  • Radiant Sage LLC
  • Resonance Health Ltd
  • Signant Health

Overall world revenue for clinical trial imaging market, 2023 to 2033 in terms of value the market will surpass US$1,370.7 million in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the clinical trial imaging market, 2023 to 2033 report help you?

In summary, our 270+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for clinical trial imaging market, 2023 to 2033 Market, with forecasts for software and services, modality, therapeutics, end users and company size, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the clinical trial imaging Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the clinical trial imaging Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the clinical trial imaging market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Clinical Trial Imaging Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
      • 3.2.1.2 Increasing demand for more precise and personalized treatments and diagnosis
      • 3.2.1.3 Technological advancements in imaging modalities
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Shortage and high costs of skilled professional
      • 3.2.2.2 High cost of imaging equipment and services
      • 3.2.2.3 Regulatory Challenges
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Outsourcing of imaging services
      • 3.2.3.2 Growing prevalence of chronic diseases
      • 3.2.3.3 Increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Clinical Trial Imaging Market Analysis by Software and Services

  • 4.1 Key Findings
  • 4.2 Software and Services Segment: Market Attractiveness Index
  • 4.3 Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
  • 4.4 Services
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.3 Services, 2023-2033 (US$ Million)
  • 4.5 Software
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Clinical Trial Imaging Market Analysis by Modality

  • 5.1 Key Findings
  • 5.2 Modality Segment: Market Attractiveness Index
  • 5.3 Clinical Trial Imaging Market Size Estimation and Forecast by Modality
  • 5.4 Computed Tomography
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Magnetic Resonance Imaging
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Ultrasound
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 5.7 Positron Emission Tomography
    • 5.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.7.2 Market Share by Region, 2023 & 2033 (%)
  • 5.8 X-ray
    • 5.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.8.2 Market Share by Region, 2023 & 2033 (%)
  • 5.9 Echocardiography
    • 5.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.9.2 Market Share by Region, 2023 & 2033 (%)

6 Clinical Trial Imaging Market Analysis by Therapeutic Area

  • 6.1 Key Findings
  • 6.2 Therapeutic Area Segment: Market Attractiveness Index
  • 6.3 Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
  • 6.4 Oncology
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Infectious diseases
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Neurology
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 CVS
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Endocrinology
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)
  • 6.9 Immunological Disorder
    • 6.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.9.2 Market Share by Region, 2023 & 2033 (%)

7 Clinical Trial Imaging Market Analysis by End Users

  • 7.1 Key Findings
  • 7.2 End Users Segment: Market Attractiveness Index
  • 7.3 Clinical Trial Imaging Market Size Estimation and Forecast by End Users
  • 7.4 Pharmaceutical Companies
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Biotechnology Companies
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Medical Device Manufacturer
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Contract Research Organizations
    • 7.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)
  • 7.8 Academic and Government Research Institutes
    • 7.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Clinical Trial Imaging Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Clinical Trial Imaging Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Clinical Trial Imaging Market Attractiveness Index
  • 9.3 North America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 9.4 North America Clinical Trial Imaging Market Size Estimation and Forecast by Country
  • 9.5 North America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
  • 9.6 North America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
  • 9.7 North America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
  • 9.8 North America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
  • 9.9 U.S. Clinical Trial Imaging Market Analysis
  • 9.10 Canada Clinical Trial Imaging Market Analysis

10 Europe Clinical Trial Imaging Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Clinical Trial Imaging Market Attractiveness Index
  • 10.3 Europe Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 10.4 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Country
  • 10.5 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
  • 10.6 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Modality
  • 10.7 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
  • 10.8 Europe Clinical Trial Imaging Market Size Estimation and Forecast by End Users
  • 10.9 Germany Clinical Trial Imaging Market Analysis
  • 10.10 France Clinical Trial Imaging Market Analysis
  • 10.11 U.K. Clinical Trial Imaging Market Analysis
  • 10.12 Italy Clinical Trial Imaging Market Analysis
  • 10.13 Spain Clinical Trial Imaging Market Analysis
  • 10.14 Russia Clinical Trial Imaging Market Analysis
  • 10.15 Rest of Europe Clinical Trial Imaging Market Analysis

11 Asia Pacific Clinical Trial Imaging Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
  • 11.3 Asia Pacific Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 Asia Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Country
  • 11.5 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
  • 11.6 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Modality
  • 11.7 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
  • 11.8 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by End Users
  • 11.9 China Clinical Trial Imaging Market Analysis
  • 11.10 Japan Clinical Trial Imaging Market Analysis
  • 11.11 India Clinical Trial Imaging Market Analysis
  • 11.12 Australia Clinical Trial Imaging Market Analysis
  • 11.13 South Korea clinical trial imaging Market Analysis
  • 11.14 Rest of Asia Pacific Clinical Trial Imaging Market Analysis

12 Latin America Clinical Trial Imaging Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Clinical Trial Imaging Market Attractiveness Index
  • 12.3 Latin America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Country
  • 12.5 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
  • 12.6 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
  • 12.7 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
  • 12.8 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
  • 12.9 Brazil Clinical Trial Imaging Market Analysis
  • 12.10 Mexico Clinical Trial Imaging Market Analysis
  • 12.11 Rest of Latin America Clinical Trial Imaging Market Analysis

13 MEA Clinical Trial Imaging Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Clinical Trial Imaging Market Attractiveness Index
  • 13.3 MEA Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Country
  • 13.5 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
  • 13.6 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Modality
  • 13.7 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
  • 13.8 MEA Clinical Trial Imaging Market Size Estimation and Forecast by End Users
  • 13.9 GCC Clinical Trial Imaging Market Analysis
  • 13.10 South Africa Clinical Trial Imaging Market Analysis
  • 13.11 Rest of MEA Clinical Trial Imaging Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2022
  • 14.2 Strategic Outlook
  • 14.3 ICON plc
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Revenue, 2018-2022
      • 14.3.3.2 Regional Market Shares, 2022
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 BioTelemetry, a Philips Company
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Revenue, 2018-2022
      • 14.4.3.2 Regional Market Shares, 2021
      • 14.4.3.3 R&D Expense, 2017-2021
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 Clario
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Product Benchmarking
    • 14.5.4 Strategic Outlook
  • 14.6 Navitas Life Sciences
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Product Benchmarking
    • 14.6.4 Strategic Outlook
  • 14.7 Resonance Health Ltd
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Revenue, 2018-2021
      • 14.7.3.2 Regional Market Shares, 2021
    • 14.7.4 Product Benchmarking
  • 14.8 Parexel International Corporation
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Product Benchmarking
    • 14.8.4 Strategic Outlook
  • 14.9 Medrio, Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Product Benchmarking
    • 14.9.4 Strategic Outlook
  • 14.10 Signant Health
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Product Benchmarking
    • 14.10.4 Strategic Outlook
  • 14.11 Perspectum
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Product Benchmarking
    • 14.11.4 Strategic Outlook
  • 14.12 Medical Metrics, Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Product Benchmarking
  • 14.13 Calyx
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Product Benchmarking
    • 14.13.4 Strategic Outlook
  • 14.14 Radiant Sage LLC
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Product Benchmarking
  • 14.15 Medpace
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Revenue, 2018-2022
      • 14.15.3.2 Regional Market Shares, 2021
    • 14.15.4 Product Benchmarking
  • 14.16 IXICO plc
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
      • 14.16.3.1 Revenue, 2018-2022
      • 14.16.3.2 Regional Market Shares, 2021
      • 14.16.3.3 R&D Expense, 2017-2021
    • 14.16.4 Product Benchmarking
    • 14.16.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Clinical Trial Imaging Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
  • Table 1 Total Clinical Trials by Phase of Development
  • Table 2 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 6 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 8 Global Clinical Trial Imaging Market Forecast by Services, 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 9 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 10 Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 11 Computed Tomography Segment Market Forecast by Region, 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 12 Magnetic Resonance Imaging Segment Market Forecast by Region, 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 13 Ultrasound Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 14 Positron Emission Tomography Segment Market Forecast by Region, 2023-2033
  • (US$ Million, AGR%, CAGR %)
  • Table 15 X-ray Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 16 Echocardiography Segment Market Forecast by Region, 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 17 Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Mn,
  • AGR%, CAGR %)
  • Table 18 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 20 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 21 CVS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 22 Endocrinology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 23 Immunology Disorder Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 24 Clinical Trial Imaging Market Forecast by End User, 2023-2033 (US$ Mn, AGR%, CAGR%)
  • Table 25 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 26 Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 27 Medical Device Manufacturer Segment Market Forecast by Region, 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 28 Contract Research Organizations Segment Market Forecast by Region, 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 29 Academic and Government Research Institutes Segment Market Forecast by Region,
  • 2023-2033, (US$ Million, AGR%, CAGR%)
  • Table 30 Global Clinical Trial Imaging Market Forecast by Region 2023-2033, (US$ Mn, AGR%, CAGR%)
  • Table 31 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 32 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 33 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 34 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 35 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 36 U.S. Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 37 Canada Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
  • Table 38 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million,
  • AGR%, CAGR %)
  • Table 39 Europe Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 40 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 41 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 42 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 43 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 44 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 45 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 46 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 47 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 48 Russia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 49 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 50 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 51 Asia Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 52 Asia Pacific Clinical Trial Imaging Market Forecast by Modality 2023-2033(US$ Million,
  • AGR%, CAGR%)
  • Table 53 Asia Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 54 Asia Pacific Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 55 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 56 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 57 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 58 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 59 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 60 Asia-Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 61 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 62 Latin America Clinical Trial Imaging Market Forecast by Software & Serices, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 63 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 64 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-

2033 (US$ Million, AGR%, CAGR%)

  • Table 65 Latin America Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 66 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 67 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 68 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 69 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 70 MEA Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 71 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
  • AGR%, CAGR%)
  • Table 72 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area 2023-2033
  • (US$ Million, AGR%, CAGR%)
  • Table 73 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 74 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 75 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 76 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 77 Strategic Outlook
  • Table 78 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 ICON plc: Product Benchmarking
  • Table 80 ICON plc: Strategic Outlook
  • Table 81 BioTelemetry, A Philips Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 BioTelemetry, A Philips Company: Product Benchmarking
  • Table 83 BioTelemetry, A Philips Company: Strategic Outlook
  • Table 84 Clario: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Clario: Product Benchmarking
  • Table 86 Clario: Strategic Outlook
  • Table 87 Navitas Life Sciences: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Navitas Life Sciences: Product Benchmarking
  • Table 89 Navitas Life Sciences: Strategic Outlook
  • Table 90 Resonance Health Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Resonance Health Ltd: Product Benchmarking
  • Table 92 Parexel International Corporation: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Parexel International Corporation.: Product Benchmarking
  • Table 94 Parexel International Corporation: Strategic Outlook
  • Table 95 Medrio, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Medrio, Inc.: Product Benchmarking
  • Table 97 Medrio, Inc.: Strategic Outlook
  • Table 98 Signant Health: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Signant Health: Product Benchmarking
  • Table 100 Signant Health: Strategic Outlook
  • Table 101 Perspectum: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Perspectum: Product Benchmarking
  • Table 103 Perspectum: Strategic Outlook
  • Table 104 Medical Metrics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Medical Metrics, Inc.: Product Benchmarking
  • Table 106 Calyx: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Calyx: Product Benchmarking
  • Table 108 Calyx: Strategic Outlook
  • Table 109 Radiant Sage LLC: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Radiant Sage LLC: Product Benchmarking
  • Table 111 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Medpace: Product Benchmarking
  • Table 113 IXICO plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 IXICO plc: Product Benchmarking
  • Table 115 IXICO plc: Strategic Outlook

List of Figures

  • Figure 1 Clinical Trial Imaging Market Segmentation
  • Figure 2 Clinical Trial Imaging Market by Software and Services: Market Attractiveness Index
  • Figure 3 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
  • Figure 4 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
  • Figure 5 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
  • Figure 6 Clinical Trial Imaging Market Attractiveness Index by Region
  • Figure 7 Clinical Trial Imaging Market: Market Dynamics
  • Figure 8 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 9 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 10 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 11 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 12 Clinical Trial Imaging Market: Porter's Five Forces Analysis
  • Figure 13 Clinical Trial Imaging Market: PEST Analysis
  • Figure 14 Clinical Trial Imaging Market Forecast by Software And Services: Market Attractiveness Index
  • Figure 15 Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
  • Figure 16 Clinical Trial Imaging Market Share Forecast by Software and Services, 2023, 2028, 2033 (%)
  • Figure 17 Services Market Forecast by Region, 2023 2033 (US$ Million)
  • Figure 18 Services Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 19 Services Market Forecast by Region, 2023 2033 (US$ Million)
  • Figure 20 Clinical Trial Imaging Market Share Forecast by Services, 2023, 2028, 2033 (%)
  • Figure 21 Software Market Forecast by Region, 2023-2033 (US$ million)
  • Figure 22 Software Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 23 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
  • Figure 24 Clinical Trial Imaging Market Forecast By Modality, 2023-2033 (US$ Million)
  • Figure 25 Clinical Trial Imaging Market Share Forecast by Modality, 2023, 2028, 2033 (%)
  • Figure 26 Computed Tomography Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 27 Computed Tomography Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Magnetic Resonance Imaging Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 29 Magnetic Resonance Imaging Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Ultrasound Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 31 Ultrasound Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 32 Positron Emission Tomography Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 33 Positron Emission Tomography Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 X-ray Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 35 X-ray Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Echocardiography Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 37 Echocardiography Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
  • Figure 39 Clinical Trial Imaging Market Forecast By Therapeutic Area, 2023-2033 (US$ Million)
  • Figure 40 Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
  • Figure 41 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 42 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 43 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 44 Infectious diseases Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Neurology Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 46 Neurology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 CVS Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 48 CVS Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 49 Endocrinology Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 50 Endocrinology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 51 Immunological Disorder Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 52 Immunological Disorder Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 53 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
  • Figure 54 Clinical Trial Imaging Market Forecast By End Users, 2023-2033 (US$ Million)
  • Figure 55 Clinical Trial Imaging Market Share Forecast by End Users, 2023, 2028, 2033 (%)
  • Figure 56 Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 57 Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 58 Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 59 Biotechnology Companies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 60 Medical Device Manufacturer Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 61 Medical Device Manufacturer Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 62 Contract Research Organizations Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 63 Contract Research Organizations Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 64 Academic and Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million)
  • Figure 65 Academic and Government Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 66 Clinical Trial Imaging Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
  • Figure 67 Clinical Trial Imaging Market Share Forecast by Region 2023, 2028, 2033(%)
  • Figure 68 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
  • Figure 69 North America Clinical Trial Imaging Market Attractiveness Index
  • Figure 70 North America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 71 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 72 North America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 73 North America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
  • Figure 74 North America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
  • Figure 75 North America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
  • Figure 76 North America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
  • Figure 77 North America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
  • Figure 78 North America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 79 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
  • Figure 80 North America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
  • Figure 81 U.S. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 82 Canada Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 83 Europe Clinical Trial Imaging Market Attractiveness Index
  • Figure 84 Europe Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 85 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 86 Europe Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 87 Europe Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ Million)
  • Figure 88 Europe Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
  • Figure 89 Europe Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
  • Figure 90 Europe Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
  • Figure 91 Europe Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
  • Figure 92 Europe Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 93 Europe Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
  • Figure 94 Europe Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
  • Figure 95 Germany Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 96 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 97 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 98 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 99 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 100 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 101 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 102 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
  • Figure 103 Asia Pacific Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 104 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 105 Asia Pacific Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 106 Asia-Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
  • Figure 107 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
  • Figure 108 Asia-Pacific Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
  • Figure 109 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
  • Figure 110 Asia-Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
  • Figure 111 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 112 Asia-Pacific Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ million)
  • Figure 113 Asia-Pacific Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
  • Figure 114 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 115 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 116 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 117 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 118 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 119 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
  • Figure 120 Latin America Clinical Trial Imaging Market Attractiveness Index
  • Figure 121 Latin America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 122 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 123 Latin America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 124 Latin America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ million)
  • Figure 125 Latin America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
  • Figure 126 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
  • Figure 127 Latin America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
  • Figure 128 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
  • Figure 129 Latin America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 130 Latin America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
  • Figure 131 Latin America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
  • Figure 132 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 133 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 134 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 135 MEA Clinical Trial Imaging Market Attractiveness Index
  • Figure 136 MEA Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 137 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
  • Figure 138 MEA Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 139 MEA Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ million)
  • Figure 140 MEA Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
  • Figure 141 MEA Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
  • Figure 142 MEA Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
  • Figure 143 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
  • Figure 144 MEA Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
  • Figure 145 MEA Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
  • Figure 146 MEA Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
  • Figure 147 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 148 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 149 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 150 Clinical Trial Imaging Market: Company Share/Ranking, 2022
  • Figure 151 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR%)
  • Figure 152 ICON plc: Regional Market Shares, 2022
  • Figure 153 BioTelemetry, A Philips Company: Revenue, 2018-2022 (US$ Million, AGR%)
  • Figure 154 BioTelemetry, A Philips Company: Regional Market Shares, 2022
  • Figure 155 BioTelemetry, A Philips Company: R&D Expense, 2018-2022 (US$ Million, AGR%)
  • Figure 156 Resonance Health Ltd: Revenue, 2018-2021 (US$ Million, AGR%)
  • Figure 157 Resonance Health Ltd: Regional Market Shares, 2021
  • Figure 158 Medpace: Revenue, 2018-2022 (US$ Million, AGR%)
  • Figure 159 Medpace: Regional Market Shares, 2022
  • Figure 160 IXICO plc: Revenue, 2018-2022 (US$ Million, AGR%)
  • Figure 161 IXICO plc: Regional Market Shares, 2022
  • Figure 162 IXICO plc: R&D Expense, 2018-2022 (US$ Million, AGR%)